Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The role of tumor-infiltrating immune cells in the early metastatic invasion of colorectal cancer is unknown. METHODS: We studied pathological signs of early metastatic invasion (venous emboli and lymphatic and perineural invasion) in 959 specimens of resected colorectal cancer. The local immune response within the tumor was studied by flow cytometry (39 tumors), low-density-array real-time polymerase-chain-reaction assay (75 tumors), and tissue microarrays (415 tumors). RESULTS: Univariate analysis showed significant differences in disease-free and overall survival according to the presence or absence of histologic signs of early metastatic invasion (P<0.001). Multivariate Cox analysis showed that an early conventional pathological tumor-node-metastasis stage (P<0.001) and the absence of early metastatic invasion (P=0.04) were independently associated with increased survival. As compared with tumors with signs of early metastatic invasion, tumors without such signs had increased infiltrates of immune cells and increased levels of messenger RNA (mRNA) for products of type 1 helper effector T cells (CD8, T-BET [T-box transcription factor 21], interferon regulatory factor 1, interferon-gamma, granulysin, and granzyme B) but not increased levels of inflammatory mediators or immunosuppressive molecules. The two types of tumors had significant differences in the levels of expression of 65 combinations of T-cell markers, and hierarchical clustering showed that markers of T-cell migration, activation, and differentiation were increased in tumors without signs of early metastatic invasion. The latter type of tumors also had increased numbers of CD8+ T cells, ranging from early memory (CD45RO+CCR7-CD28+CD27+) to effector memory (CD45RO+CCR7-CD28-CD27-) T cells. The presence of high levels of infiltrating memory CD45RO+ cells, evaluated immunohistochemically, correlated with the absence of signs of early metastatic invasion, a less advanced pathological stage, and increased survival. CONCLUSIONS: Signs of an immune response within colorectal cancers are associated with the absence of pathological evidence of early metastatic invasion and with prolonged survival.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Examination of the lymphocytes that correlated with such beneficial outcomes has repeatedly implicated effector and memory CD8 + T cell and NK cell populations (136-141).”
From Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance (2021) · cites this paper as [136]
Citations
Cites
Cluster analysis and display of genome-wide expression patterns
Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 16,184
TNM Classification of Malignant Tumours
(1987) · Springer eBooks · doi:10.1007/978-3-642-82982-6 · Cited by 16,049
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
TNM Classification of Malignant Tumors
Carter, D. (1998) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199810000-00016 · Cited by 6,330
Cancer immunoediting: from immunosurveillance to tumor escape
Dunn, G. P., Bruce, A. T., Ikeda, H., Old, L. J., & Schreiber, R. D. (2002) · Nature Immunology · doi:10.1038/ni1102-991 · Cited by 5,393
TNM Classification of Malignant Tumours
(2003) · John Wiley & Sons, Inc. eBooks · doi:10.1002/0471463752 · Cited by 3,946
Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
Zhang, L., Conejo-Garcia, J. R., Katsaros, D., Gimotty, P. A., Massobrio, M., Regnani, G., Makrigiannakis, A., Gray, H., Schlienger, K., Liebman, M. N., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020177 · Cited by 3,397
Tumour-educated macrophages promote tumour progression and metastasis
Pollard, J. W. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1256 · Cited by 3,367
The Three Es of Cancer Immunoediting
Dunn, G. P., Old, L. J., & Schreiber, R. D. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104803 · Cited by 3,072
Central Memory and Effector Memory T Cell Subsets: Function, Generation, and Maintenance
Sallusto, F., Geginat, J., & Lanzavecchia, A. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104702 · Cited by 3,067
Research works printed but not linked: 2
- 10.1002/(sici)1097-0142(20000401)88:7<1739::aid-cncr30>3.0.co;2-t · DOI · Paper page
- 10.1002/(sici)1097-0215(19990621)84:3<326::aid-ijc22>3.0.co;2-k · DOI · Paper page
Cited by
Items 701–800 of 1,001
Morre, M., & Beq, S. (2012) · Targeted Oncology · doi:10.1007/s11523-012-0210-4 · Cited by 51
“established the association between increased survival and a high level of infiltrating memory T cells (CD45RO+), an absence of signs of early metastatic invasion, and a less advanced pathological state [35].”
BackgroundDevaud, C., Rousseau, B., Netzer, S., Pitard, V., Paroissin, C., Khairallah, C. F., Costet, P., Moreau, J., Couillaud, F., Déchanet‐Merville, J., et al. (2013) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-013-1402-1 · Cited by 65
Moore, J., Hyman, N., CALLAS, P. W., et al. (2009) · Surgery · doi:10.1016/j.surg.2009.10.003 · Cited by 51
Saigusa, S., Toiyama, Y., Tanaka, K., Inoue, Y., Mori, K., Ide, S., Imaoka, H., Kawamura, M., Mohri, Y., & Kusunoki, M. (2016) · International Journal of Clinical Oncology · doi:10.1007/s10147-016-0962-4 · Cited by 52
Improving homing in T cell therapy
Vignali, D., & Kallikourdis, M. (2017) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2017.06.009 · Cited by 54
Alwers, E., Jia, M., Kloor, M., Bläker, H., Brenner, H., & Hoffmeister, M. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2017.12.038 · Cited by 55
“Tumors presenting with a higher count of T lymphocytes have been associated with less nodal and metastatic involvement.(54) The immunoscore has shown an association with survival in CRC, in which tumors with a higher immune infiltrate had a better survival, and were more likely to be MSI-high.”
Wang, X., Zhang, B., Chen, X., Mo, H., Wu, D., Lan, B., Li, Q., Xu, B., & Huang, J. (2019) · Thoracic Cancer · doi:10.1111/1759-7714.13083 · Cited by 52
Pedrazzani, C., Tripepi, M., Turri, G., Fernandes, E., Scotton, G., Conci, S., Campagnaro, T., Ruzzenente, A., & Guglielmi, A. (2020) · Scientific Reports · doi:10.1038/s41598-020-57721-4 · Cited by 49
Kang, S., & Tang, H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.572677 · Cited by 61
de Lima, V. A. B., Hansen, M., Spanggaard, I., Rohrberg, K. S., Hadrup, S. R., Lassen, U., & Svane, I. M. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.558248 · Cited by 65
Weixler, B., Cremonesi, E., Sorge, R. P., Muraro, M. G., Delko, T., Nebiker, C. A., Däster, S., Governa, V., Amicarella, F., Soysal, S. D., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5940 · Cited by 59
“CRC infiltration by cells expressing either marker, known to correlate with favorable clinical course [5, 6, 8, 10, 11], was also associated with favorable prognosis in our cohort of patients (data not shown).”
InfluentialClinical impact of tumor-infiltrating CD45RO+ memory T cells on human gastric cancer
Wakatsuki, K., Sho, M., YAMATO, I., Takayama, T., Matsumoto, S., Tanaka, T., Migita, K., Ito, M., Hotta, K., & Nakajima, Y. (2013) · Oncology Reports · doi:10.3892/or.2013.2302 · Cited by 54
Halama, N., Spille, A., Lerchl, T., Brand, K., Herpel, E., Welte, S., Keim, S., Lahrmann, B., Klupp, F., Kahlert, C., et al. (2013) · OncoImmunology · doi:10.4161/onci.24116 · Cited by 50
B7-H1 expression is associated with expansion of regulatory T cells in colorectal carcinoma
Hua, D., Sun, J., Mao, Y., Chen, L.-J., Wu, Y.-Y., & 张学光 (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i9.971 · Cited by 54
Tumour-infiltrating CD68+ and CD57+ cells predict patient outcome in stage II–III colorectal cancer
Chaput, N., Svrcek, M., Auperin, A., Locher, C., Drusch, F., Malka, D., Taïeb, J., Goèré, D., Ducreux, M. P., & Boige, V. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.362 · Cited by 55
Can anesthetic techniques or drugs affect cancer recurrence in patients undergoing cancer surgery?
Niwa, H., Rowbotham, D. J., Lambert, D. G., & Buggy, D. J. (2013) · Journal of Anesthesia · doi:10.1007/s00540-013-1615-7 · Cited by 50
Turksma, A. W., Coupé, V. M. H., Shamier, M. C., Lam, K. L. H., de Weger, V. A., Belien, J. A. M., van den Eertwegh, A. J., Meijer, G. A., Meijer, C. J. L. M., & Hooijberg, E. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2462 · Cited by 50
“In recent years, Galon and colleagues have introduced the concept of the so-called Immunoscore, which is aimed at providing additional prognostic value to the universally implemented TNM classification for patients with colorectal cancer, based on the presence of infiltrating T cells in the invasive margin and in the…”
BackgroundMicroRNA let-7 , T Cells, and Patient Survival in Colorectal Cancer
Dou, R., Nishihara, R., Cao, Y., Hamada, T., Mima, K., Masuda, A., Masugi, Y., Shi, Y. X., Gu, M., Li, W., et al. (2016) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-16-0112 · Cited by 52
“In colorectal cancer, the degree of infiltration of T lymphocytes, such as CD8 cytotoxic T cells and CD45RO (PTPRC) effector memory T cells, has been associated with high-level microsatellite instability (MSI-high) (4,5) and favorable prognosis (5-7).”
BackgroundNejati, R., Goldstein, J. B., Halperin, D. M., Wang, H., Hejazi, N., Rashid, A., Katz, M. H. G., Lee, J. E., Fleming, J. B., Rodriguez‐Canales, J., et al. (2017) · Pancreas · doi:10.1097/mpa.0000000000000914 · Cited by 53
Anari, F., Ramamurthy, C., & Zibelman, M. (2018) · Future Oncology · doi:10.2217/fon-2017-0585 · Cited by 50
B7-H3 immune checkpoint expression is a poor prognostic factor in colorectal carcinoma
Lu, Z., Zhao, Z., Cheng, P., Huang, F., Guan, X., Zhang, M., Chen, H., Liu, Z., Jiang, Z., Zheng, Z., et al. (2020) · Modern Pathology · doi:10.1038/s41379-020-0587-z · Cited by 53
“However, increasing studies measuring immune checkpoints and lymphocyte infiltration expression in different tumors using TMAs showed consistent results, demonstrating the reliability of this approach [18, 53, 63, 64].”
ResultWang, Z., Zeng, F., Hu, Y., Wang, X., Zhao, F., Zhou, P., Hu, J., Xiao, Y., Hu, Z., Guo, M., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00820-z · Cited by 57
“3f), which is linked to poor prognosis in human CRC patients.(34) Similar to the results obtained for MC38 xenograft model, we found that the frequency of CD8 T cells and CD8IFN-γ T cells was significantly decreased in tumors and tumor-draining lymph nodes of IL37tg mice compared with that of WT mice (Supplementary Fi…”
ResultIs lymph node count an ideal quality indicator for cancer care?
Baxter, N. N. (2008) · Journal of Surgical Oncology · doi:10.1002/jso.21197 · Cited by 49
Madsen, C. B., Lavrsen, K., Steentoft, C., Vester-Christensen, M. B., Clausen, H., Wandall, H. H., & Pedersen, A. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072413 · Cited by 56
“The presence of such tumor infiltrating immune cells is associated with an improved prognosis in many cancer forms [8–11].”
Th17 cells have stem cell-like features and promote long-term immunity
Wei, S., Zhao, E., Kryczek, I., & Zou, W. (2012) · OncoImmunology · doi:10.4161/onci.19440 · Cited by 49
“Several reports describe cells with apparent memory phenotypes in cancer patients.(3,4) One function of these cells is to produce effector molecules, such as IFNc and granzyme B, and was inferred by RNA analysis without detailed genomic and functional analysis.”
The Immunogenicity of Colorectal Cancer in Relation to Tumor Development and Treatment
Vries, N. L. D., Swets, M., Vahrmeijer, A. L., Hokland, M., & Kuppen, P. J. K. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17071030 · Cited by 52
Vahidi, Y., Faghih, Z. S., Talei, A., Doroudchi, M., & Ghaderi, A. A. (2017) · Cellular Oncology · doi:10.1007/s13402-017-0352-6 · Cited by 56
Enfield, K. S. S., Martin, S. D., Marshall, E. A., Kung, S. H. Y., Gallagher, P., Milne, K., Chen, Z., Nelson, B. H., Lam, S. C., English, J. C., et al. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-018-0488-6 · Cited by 59
Tissue Infiltrating Immune Cells as Prognostic Biomarkers in Endometrial Cancer: A Meta-Analysis
Guo, F., Dong, Y., Tan, Q., Kong, J., & Yu, B. (2020) · Disease Markers · doi:10.1155/2020/1805764 · Cited by 49
Sobral, D., Martins, M., Kaplan, S., Golkaram, M., Salmans, M., Khan, N., Vijayaraghavan, R., Casimiro, S., Fernandes, A., Borralho, P., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03884-x · Cited by 63
Tian, T., Yu, S., Liu, L., Xue, F., Yuan, C., Wang, M., Ji, C., & Ma, D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0131761 · Cited by 50
“Accumulating evidences indicate an imbalanced Th1/Th2 involved in the pathogenesis of solid tumors [6] as well as hematological malignancies [7,8].”
BackgroundInvolvement of the Leptin Receptor in the Immune Response in Intestinal Cancer
Aloulou, N., Bastuji‐Garin, S., Gouvello, S. L., Abolhassani, M., Chaumette, M. T., Charachon, A., Leroy, K., & Sobhani, I. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0909 · Cited by 51
“In CRC, although higher numbers of inflammatory cells in tumors have been shown to favor tumor progression (38), the presence of markers for Th1 and cytotoxic polarization, the memory T-cell type, a high density, and the location of immune cells within the tumor samples are associated with improved survival (17, 39, 4…”
BackgroundDarrasse-Jèze, G., & Podsypanina, K. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00292 · Cited by 48
“Together, these observations suggest that antitumor amTeffs could be inherently more resistant to Tregs, and explain why detection of amTeffs correlates with good prognosis in cancer patients (118, 119).”
BackgroundJu, S., Park, S., Lee, Y., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.26316 · Cited by 48
Peripheral Neutrophil to Lymphocyte Ratio Improves Prognostication in Colon Cancer
Rashtak, S., Ruan, X., Druliner, B. R., Liu, H., Therneau, T. M., Mouchli, M. A., & Boardman, L. A. (2017) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2017.01.008 · Cited by 54
“Signs of early metastasis such as lymphovascular and perineural invasion have been proposed to be used in clinical practice to direct targeted chemotherapy and immunotherapy.(15) Other prognostication models that focus upon clinically available data have shown promise for improving accuracy of determining a patient’s…”
BackgroundAn Expanding Role for Immunotherapy in Colorectal Cancer
Bever, K. M., & Le, D. T. (2017) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2017.0037 · Cited by 51
Massi, D., Romano, E., Rulli, E., Merelli, B., Nassini, R., Logu, F. D., Bièche, I., Baroni, G., Cattaneo, L., Xue, G., et al. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.03.012 · Cited by 53
“It has been reported that CD8þ T cells are associated with the natural history of different primary cancers [22,23], and with cancer outcome after PD-1 blockade [24].”
BackgroundEmile, J., Julié, C., Malicot, K. L., Lepage, C., Tabernero, J. M., Mini, E., Folprecht, G., Laethem, J. V., Dimet, S., Boulagnon‐Rombi, C., et al. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.04.025 · Cited by 49
Xu, A., Huang, L., Zhu, L., & Wei, Z. (2014) · Europe PMC (PubMed Central) · Cited by 52
Immune Suppressive Effects of Plasma-Derived Exosome Populations in Head and Neck Cancer
Beccard, I. J., Hofmann, L., Schroeder, J. C., Ludwig, S., Laban, S. A., Brunner, C., Lotfi, R., Hoffmann, T. K., Jackson, E. K., Schuler, P. J., et al. (2020) · Cancers · doi:10.3390/cancers12071997 · Cited by 54
“Since a strong presence of CD8+ T cells in the TME is generally associated with a better prognosis [26,27] and intra-tumoral accumulation of Treg predicts resistance to treatments and accelerated cancer progression [28], evaluation of regulating mechanisms of immune cell populations, especially T cell fractions, remai…”
BackgroundMHC class II molecules in tumour immunology: Prognostic marker and target for immune modulation
Chamuleau, M. E. D., Ossenkoppele, G. J., & van de Loosdrecht, A. A. (2006) · Immunobiology · doi:10.1016/j.imbio.2006.05.005 · Cited by 51
A Macrophage Gene Expression Signature Defines a Field Effect in the Lung Tumor Microenvironment
Stearman, R. S., Dwyer-Nield, L., Grady, M. C., Malkinson, A. M., & Geraci, M. W. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-0988 · Cited by 48
“The influence of immune cell infiltration on metastatic potential and patient survival has been examined in patients with colorectal cancer (44, 45).”
BackgroundHwang, H. K., Kim, H., Kim, S. H., Choi, J., Kang, C. M., Kim, K. S., & Lee, W. J. (2016) · Oncology Letters · doi:10.3892/ol.2016.5252 · Cited by 49
B7-H1 limits the entry of effector CD8+T cells to the memory pool by upregulating Bim
Gibbons, R., Liu, X., Pulko, V., Harrington, S. M., Krco, C. J., Kwon, E. D., & Dong, H. (2012) · OncoImmunology · doi:10.4161/onci.20850 · Cited by 49
Epigenetic Modulation to Enable Antigen-specific T-cell Therapy of Colorectal Cancer
Chou, J., Voong, L. N., Mortales, C., Towlerton, A. M. H., Pollack, S. M., Chen, X., Yee, C., Robbins, P. F., & Warren, E. H. (2012) · Journal of Immunotherapy · doi:10.1097/cji.0b013e31824300c7 · Cited by 55
Søndergaard, H., Galsgaard, E. D., Bartholomæussen, M., Straten, P. T., Ødum, N., & Skak, K. (2010) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3181c0c1cb · Cited by 53
Stübig, T., Badbaran, A., Luetkens, T., Hildebrandt, Y., Atanackovic, D., Binder, T. M. C., Fehse, B., & Kröger, N. M. (2014) · Mediators of Inflammation · doi:10.1155/2014/418292 · Cited by 62
“Due to our findings indicating a differentiation capacity of 5-Aza especially in Treg and Th1 cells, we further analyzed its impact on the naı̈ve and memory T-populations required for an effective antitumor immunity [43].”
Turcotte, S., Katz, S. C., Shia, J., Jarnagin, W. R., Kingham, T. P., Allen, P. J., Fong, Y., D'Angelica, M. I., & DeMatteo, R. P. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0180 · Cited by 56
“In addition, the intratumoral T-cell density and quality have been inversely correlated with colorectal cancer progression (4, 5).”
BackgroundFumet, J.-D., Isambert, N., Hervieu, A., Zanetta, S., Guion, J.-F., Hennequin, A., Rederstorff, E., Bertaut, A., & Ghiringhelli, F. (2018) · ESMO Open · doi:10.1136/esmoopen-2018-000375 · Cited by 48
“Many studies highlight the fact that CRC can be recognised by the immune system and it is well admitted that high CD8 T cell infiltrates are associated with better cancer prognosis in localised or metastatic CRC.(11) 12 This discovery was linked to the development of recent immunotherapies in cancer treatment.”
BackgroundInfluentialModulation of CD103 Expression on Human Colon Carcinoma-Specific CTL
Ling, K., Dulphy, N., Bahl, P., Salio, M., Maskell, K., Piris, J., Warren, B. F., George, B. D., Mortensen, N. J. M., & Cerundolo, V. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.5.2908 · Cited by 54
“T he role of T lymphocytes in controlling the growth of colon carcinoma has been described recently by comparing the percentage of tumor-infiltrating CD3 lymphocytes and patients’ survival (1, 2).”
BackgroundWagner, P., Koch, M., Nummer, D., Palm, S., Galindo, L., Autenrieth, D., Schmitz-Winnenthal, F. H., Schirrmacher, V., Büchler, M. W., Beckhove, P., et al. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-008-9971-5 · Cited by 51
Frigola, J., Navarro, A., Carbonell, C., Callejo, A., Iranzo, P., Cedrés, S., Martínez‐Martí, A., Pardo, N., Gonzalez, N. S., Martinez, D., et al. (2021) · Molecular Oncology · doi:10.1002/1878-0261.12891 · Cited by 53
Heras‐Murillo, I., Mañanes, D., Munné, P., Núñez, V., Herrera, J., Català-Montoro, M., Álvarez, M., del Pozo, M. Á., Melero, I., Wculek, S. K., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-58289-1 · Cited by 64
“Simple depletion studies would provide at least some insights, but the use of aDC1s from animals lacking key mediators (IL-12, other cytokines, chemokines) would allow for a much better picture.”
T-cell intracellular antigens in health and disease
Sánchez-Jiménez, C., & Izquierdo, J. M. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1053668 · Cited by 51
Tumor Immuno-Environment in Cancer Progression and Therapy
Kaliński, P., & Talmadge, J. E. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-67577-0_1 · Cited by 52
Sun, F., Peng, H.-X., Gao, Q., Li, S., Zhang, J., Chen, Q.-G., Jiang, Y., Zhang, L., Wang, X.-Z., & Ying, H. (2018) · Cancer Management and Research · doi:10.2147/cmar.s167398 · Cited by 47
Immune Landscape in Tumor Microenvironment: Implications for Biomarker Development and Immunotherapy
Pérez‐Romero, K., Rodríguez, R. M. A., Amedei, A., Barceló‐Coblijn, G., & Lopez, D. H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155521 · Cited by 52
“showed that the immune response within colorectal cancer was associated with prolonged survival [22].”
BackgroundLactate-related metabolic reprogramming and immune regulation in colorectal cancer
Sun, Q., Wu, J., Zhu, G., Li, T., Zhu, X., Ni, B., Xu, B., Ma, X., & Li, J. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1089918 · Cited by 61
“They play an essential role in the pathogenesis and progression of CRC (45), mainly including helper CD4T cells and cytotoxic CD8T cells.”
BackgroundStevens-Johnson syndrome and toxic epidermal necrolysis in patients with malignancies
Wu, J., Lee, Y.-A., Su, S., et al. (2015) · British Journal of Dermatology · doi:10.1111/bjd.14052 · Cited by 45
Oncolytic influenza A virus expressing interleukin-15 decreases tumor growth in vivo
Hock, K., Laengle, J., Kuznetsova, I., Egorov, A., Hegedűs, B., Döme, B., Wekerle, T., Sachet, M., & Bergmann, M. M. (2016) · Surgery · doi:10.1016/j.surg.2016.08.045 · Cited by 45
Immunoprofiling as a predictor of patient’s response to cancer therapy—promises and challenges
Bethmann, D., Feng, Z., & Fox, B. A. (2017) · Current Opinion in Immunology · doi:10.1016/j.coi.2017.01.005 · Cited by 57
Lang‐Schwarz, C., Melcher, B., Haumaier, F., Lang-Schwarz, K., Rupprecht, T., Vieth, M., & Sterlacci, W. (2018) · Human Pathology · doi:10.1016/j.humpath.2018.05.010 · Cited by 49
Tumor-Infiltrating Lymphocytes in Breast Cancer
Khoury, T., Peng, X., Yan, L., Wang, D., & Nagrale, V. (2018) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqy069 · Cited by 45
“A number of clinical studies have shown that the presence of tumor-infiltrating lymphocytes (TILs) in various types of cancer tissues is associated with improved outcome.(1,2) Interest in TILs in breast cancer (BC) has rapidly gained momentum due to the accumulated studies showing that TILs play a role in tumor respon…”
BackgroundFloudas, C. S., Brar, G. S., Mabry‐Hrones, D., Duffy, A. G., Wood, B. J., Levy, E. B., Krishnasamy, V. P., Fioravanti, S., Bonilla, C. M., Walker, M., et al. (2019) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2019.06.004 · Cited by 51
Contribution of Immunoscore and Molecular Features to Survival Prediction in Stage III Colon Cancer
Sinicrope, F. A., Shi, Q., Hermitte, F., Zemla, T., Mlecnik, B., Benson, A. B., Gill, S., Goldberg, R. M., Kahlenberg, M. S., Nair, S., et al. (2020) · JNCI Cancer Spectrum · doi:10.1093/jncics/pkaa023 · Cited by 48
“Although Immunoscore has been shown to provide independent prognostic information beyond clinicopathologic variables (6,7), we emphasize our novel findings in a single tumor stage (stage III) with molecular analysis and uniform treatment compared with prior studies that have included pooled tumor stages and variable t…”
ResultSelf-citationAutophagy: A Versatile Player in the Progression of Colorectal Cancer and Drug Resistance
Manzoor, S., Muhammad, J. S., Maghazachi, A. A., & Hamid, Q. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.924290 · Cited by 45
TGFβ and the Tumor Microenvironment in Colorectal Cancer
Waldner, M. J., & Neurath, M. F. (2023) · Cells · doi:10.3390/cells12081139 · Cited by 57
Prognostic importance of tumour-infiltrating memory T cells in oesophageal squamous cell carcinoma
Enomoto, K., Sho, M., Wakatsuki, K., TAKAYAMA, T., Matsumoto, S., Nakamura, S., Akahori, T., Tanaka, T., Migita, K., Ito, M., et al. (2012) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2012.04565.x · Cited by 48
Re, V. D., Caggiari, L., Zorzi, M. D., Talamini, R., Racanelli, V., Andrea, M. D., Buonadonna, A., Zagonel, V., Cecchin, E., Innocenti, F., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084940 · Cited by 48
“NK cells provide first-line defense against malignantly transformed cells [38;39] and recent evidence of the use of antibodies blocking the immunosuppressive receptor programmed cell death 1 (PD-1) pathway underscored the central role of reinduction of host immune system and of potentiating the NK-cell mediated cytoto…”
BackgroundMüller, P., Rothschild, S. I., Walter, A., Hirschmann, P., Horvath, L., Bubendorf, L., Savic, S., & Zippelius, A. (2015) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-015-1768-3 · Cited by 46
“In contrast, a low density of T cells was associated with a poor prognosis [9, 10].”
mRNA-based vaccines synergize with radiation therapy to eradicate established tumors
Fotin-Mleczek, M., Zanzinger, K., Heidenreich, R., Lorenz, C., Kowalczyk, A., Kallen, K.-J., & Huber, S. M. (2014) · Radiation Oncology · doi:10.1186/1748-717x-9-180 · Cited by 44
“…to the presented data, a positive correlation between tumor-infiltrating T cells and favorable prognosis has been described in a variety of different cancer types such as hepatocellular carcinoma [33], pancreatic carcinoma [34,35], lung carcinoma [36], colorectal cancer [37,38] and melanoma [39].”
Tahara, H., Sato, M., Thurin, M., Wang, E., Butterfield, L. H., Disis, M. L., Fox, B. A., Lee, P. P., Khleif, S. N., Wigginton, J. M., et al. (2009) · Journal of Translational Medicine · doi:10.1186/1479-5876-7-45 · Cited by 47
Self-citationPotentiation of immunomodulatory antibody therapy with oncolytic viruses for treatment of cancer
Zamarin, D., & Wolchok, J. D. (2014) · Molecular Therapy — Oncolytics · doi:10.1038/mto.2014.4 · Cited by 47
Xing, J., Zhang, C., Yang, X., Wang, S., Wang, Z., Xu, L., & Yu, E. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.04.014 · Cited by 45
Zhuo, M., Chen, H., Zhang, T., Yang, X., Zhong, J., Wang, Y., An, T., Wu, M., Wang, Z., Huang, J., et al. (2018) · Cancer Biomarkers · doi:10.3233/cbm-171089 · Cited by 44
Determinants of Resistance to Checkpoint Inhibitors
Tran, L. L., & Theodorescu, D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051594 · Cited by 47
Alexe, G., Monaco, J., Doyle, S. T., Basavanhally, A. N., Reddy, A., Seiler, M., Ganesan, S., Bhanot, G., & Madabhushi, A. (2009) · Experimental Biology and Medicine · doi:10.3181/0902-mr-89 · Cited by 45
Rationale of Immunotherapy in Hepatocellular Carcinoma and Its Potential Biomarkers
Tai, D. W.-M., Choo, S. P., & Chew, V. (2019) · Cancers · doi:10.3390/cancers11121926 · Cited by 46
Prognostic impact of peritumoral lymphocyte infiltration in soft tissue sarcomas
Sørbye, S. W., Kilvaer, T. K., Valkov, A., Dønnem, T., Smeland, E., Al-Shibli, K. I., Bremnes, R. M., & Busund, L. (2012) · BMC Clinical Pathology · doi:10.1186/1472-6890-12-5 · Cited by 86
“CD8+ cells in malignant tumors have been associated with an improved DSS in: non-small cell lung carcinoma; carcinomas of the endometrium, bile duct, colon, oesophagus, and urothelium; uveal melanoma; and follicular lymphoma [22,31-40].”
BackgroundTamura, K., Hazama, S., Yamaguchi, R., Imoto, S., Takenouchi, H., Inoue, Y., Kanekiyo, S., Shindo, Y., Miyano, S., Nakamura, Y., et al. (2016) · Oncology Letters · doi:10.3892/ol.2016.4465 · Cited by 45
Ma, Q., Liu, J., Wu, G., Teng, M., Wang, S., Cui, M., & Li, Y. (2018) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12992 · Cited by 47
Identification of immune cells and mRNA associated with prognosis of gastric cancer
Wang, M., Li, Z., Peng, Y., Fang, J., Fang, T., Wu, J., & Zhou, J. (2020) · BMC Cancer · doi:10.1186/s12885-020-6702-1 · Cited by 50
IL22BP Mediates the Antitumor Effects of Lymphotoxin Against Colorectal Tumors in Mice and Humans
Kempski, J., Giannou, A. D., Riecken, K., Zhao, L., Steglich, B., Lücke, J., Pérez, L. G., Karstens, K.-F., Woestemeier, A., Nawrocki, M., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.06.033 · Cited by 48
Baldin, P., den Eynde, M. V., Mlecnik, B., Bindea, G., Beniuga, G., Carrasco, J., Haicheur, N., Marliot, F., Lafontaine, L., Fredriksen, T., et al. (2020) · The Journal of Pathology Clinical Research · doi:10.1002/cjp2.178 · Cited by 52
Self-citationObesity-associated cancer: an immunological perspective
Conroy, M. J., Dunne, M. R., Donohoe, C. L., & Reynolds, J. V. (2015) · Proceedings of The Nutrition Society · doi:10.1017/s0029665115004176 · Cited by 48
Lü, L., Gao, Y., Huang, D., Liu, H., Yin, D., Li, M., Zheng, J., Wang, S., Wu, W., Zhao, L., et al. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2023-007447 · Cited by 55
Salama, P. R., Phillips, M. R., Platell, C. F. E., & Iacopetta, B. J. (2011) · Histopathology · doi:10.1111/j.1365-2559.2011.03915.x · Cited by 50
“More recently, Galon et al.11,12 claimed the type, density and location of tumourinfiltrating immune cells was strongly predictive of clinical outcome and was even superior to the currently used tumour–node–metastasis (TNM) staging system.”
ResultGut macrophage phenotype is dependent on the tumor microenvironment in colorectal cancer
Norton, S. E., Dunn, E. T. J., McCall, J. L., Munro, F., & Kemp, R. A. (2016) · Clinical & Translational Immunology · doi:10.1038/cti.2016.21 · Cited by 42
Abe, S., Kawai, K., Ishihara, S., Nozawa, H., Hata, K., Kiyomatsu, T., Tanaka, T., & Watanabe, T. (2016) · Journal of Surgical Research · doi:10.1016/j.jss.2016.06.078 · Cited by 42
Growth and metastasis of lung adenocarcinoma is potentiated by BMP4-mediated immunosuppression
Chen, L., Yi, X., Goswami, S., Ahn, Y., Roybal, J. D., Yang, Y., Diao, L., Peng, D., Peng, D. H., Fradette, J. J., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1234570 · Cited by 46
Obermajer, N., Urban, J. A., Wieckowski, E. U., Muthuswamy, R., Ravindranathan, R., Bartlett, D. L., & Kaliński, P. (2018) · Nature Protocols · doi:10.1038/nprot.2017.130 · Cited by 41
Epithelial Neoplasms of the Large Intestine
Redston, M. S. (2009) · Elsevier eBooks · doi:10.1016/b978-141604059-0.50026-6 · Cited by 47
The P2X7 Receptor in Tumor Immunity
Grassi, F., & Conti, B. D. P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.694831 · Cited by 54
OX40-Enhanced Tumor Rejection and Effector T Cell Differentiation Decreases with Age
Ruby, C. E., & Weinberg, A. D. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.3.1481 · Cited by 42
“In cancer patients, the generation and accumulation of effector T cells are critical for effective antitumor responses, as the presence of these cells within tumors in large numbers represents a positive clinical prognosis (26, 27).”
BackgroundPetrausch, U., Haley, D. P., Miller, W. L., Floyd, K., Urba, W. J., & Walker, E. (2006) · Cytometry Part A · doi:10.1002/cyto.a.20342 · Cited by 43
“These relative frequencies are accessible for cluster algorithms as shown in recent studies that analyzed lymphocyte subsets defined using 4-color flow cytometry in patients with colorectal cancer (10), and in patients with B cell”
BackgroundMethodLee, S., Miyai, K., Han, H. S., Hwang, D., Seong, M. K., Chung, H., Jung, B. H., Devaraj, B., McGuire, K. L., & Carethers, J. M. (2011) · Digestive Diseases and Sciences · doi:10.1007/s10620-011-1825-5 · Cited by 42
“Some studies indicate the CD8? T cells suppress cancer cell growth and micrometastasis, whereas CD4? T cells causes degeneration of tumor cells [6].”
The evolving landscape of PCSK9 inhibition in cancer
Oza, P. P., & Kashfi, K. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175721 · Cited by 44
Stoll, G., Bindea, G., Mlecnik, B., Galon, J., Zitvogel, L., & Kroemer, G. (2015) · Oncotarget · doi:10.18632/oncotarget.4180 · Cited by 41
“com/oncotarget memory effector T cell phenotype [7-9], as well as that of conventional dendritic cells, has a positive prognostic impact on cancer patients, in particular if such cells are found within tumor nodules instead of the surrounding stroma [10].”
BackgroundSelf-citationKiller dendritic cells: IKDC and the others
Bonmort, M., Dalod, M., Mignot, G., Ullrich, E., Chaput, N., & Zitvogel, L. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2008.04.006 · Cited by 41
Maker, A. V., Ito, H., Mo, Q., Weisenberg, E., Qin, L., Turcotte, S., Maithel, S. K., Shia, J., Blumgart, L. H., Fong, Y., et al. (2015) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0212 · Cited by 45
Metadata
- Authors
- Pagès, F., Berger, A., Camus, M., Sanchez-Cabo, F., Costes, A., Molidor, R., Mlecnik, B., Kirilovsky, A., Nilsson, M., Damotte, D., Meatchi, T., Bruneval, P., Cugnenc, P.-H., Trajanoski, Z., Fridman, W.-H., & Galon, J.
- Affiliations
- Inserm (FR)
- Hôpital Européen Georges-Pompidou (FR)
- Graz University of Technology (AT)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-12-22
- Volume
- 353
- Issue
- 25
- Pages
- 2654-2666
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2096151993
- Semantic Scholar
- 608c79dfb95b1632f3cda7f427350880ee435e8a
- Cited by
- 2,135
- References
- 32
- Citations by year
- 2026: 27 · 2025: 57 · 2024: 66 · 2023: 118 · 2022: 117 · 2021: 141 · 2020: 130 · 2019: 123 · 2018: 123 · 2017: 136 · 2016: 135 · 2015: 145 · 2014: 115 · 2013: 135 · 2012: 108
- FWCI
- 27.81
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- colorectal cancer, effector memory T cells, tumor-infiltrating lymphocytes, CD8+ T cells, CD45RO+ memory T cells, T-cell markers, lymphatic invasion, perineural invasion, interferon-gamma, granzyme B, granulysin, IRF1, disease-free survival, overall survival, antitumor immunity
- MeSH terms
- Analysis of Variance, Embolism, Flow Cytometry, Humans, Lymphatic Metastasis, Neoplasm Invasiveness, Neoplasm Metastasis, Neoplasm Staging, RNA, Messenger, T-Lymphocytes, Colorectal Neoplasms, Gene Expression, Proportional Hazards Models, Survival Analysis, Polymerase Chain Reaction, Lymphocytes, Tumor-Infiltrating, Leukocyte Common Antigens, CD8-Positive T-Lymphocytes, Microarray Analysis, Protein Tyrosine Phosphatase, Non-Receptor Type 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.